Researcher Stories
Get to know the PhRMA Foundation’s award recipients.
Finding Drugs to Protect the Heart During Chemotherapy
Anh Cong, a PhD student at the Mayo Clinic Graduate School of Biomedical Sciences, is studying the sister proteins targeted by anthracycline chemotherapy drugs, which are effective against many cancers but often leave patients with heart complications.
Watch Now
Targeting Cancer’s DNA Repair Process to Improve Small Cell Lung Cancer Treatment
Texia Loh, a PhD student at Sanford Burnham Prebys Medical Discovery Institute, is researching strategies to enhance the effectiveness of treatment for small cell lung cancer.
Watch Now
Improving Antibody-Drug Conjugates for Cancer Treatment
Alina Ringaci, a PhD student at Boston University, is studying how to improve antibody-drug conjugates, a type of cancer treatment that delivers drugs directly to cancer cells.
Watch NowUnderstanding a Tiny RNA Modification’s Outsized Role in Cancer
Allison Siegenfeld, a postdoctoral trainee at Harvard Medical School, is studying a hallmark of cancer — the dysregulation of messenger RNA levels — to better understand how treatments can target this mechanism of action.
Awardee Spotlight
Yu-Hsiang Chen, MS, PhD
- University of Texas MD Anderson Cancer Center
“The PhRMA Foundation award provides me with the essential resources to advance my research on characterizing measurable residual disease in blood cancer and monitoring its evolution, along with immune cell interactions, after allogeneic stem cell transplantation. This support strengthens our mission to make a meaningful impact on cancer diagnosis and treatment.”
Turning Bad Cholesterol Into a Good Drug Delivery Vehicle
Dr. Lisa Volpatti of Northwestern University is creating a novel drug delivery system that treats inflammation by taking advantage of the body’s natural systems.